5 unchanged sentences
Issuer Purchases of Equity Securities
−Removed: The following table provides information on a monthly basis for the quarter ended September 30, 2025, with respect to the Company’s purchase of equity securities:
+Added: The following table provides information on a monthly basis for the quarter ended December 31, 2025, with respect to the Company’s purchase of equity securities:
Period Total Number
6 unchanged sentences
Under the Plans or Programs
−Removed: July 1, 2025 to July 31, 2025 1,160,582 $ 14.81 1,160,582 $ 524,684,452
−Removed: August 1, 2025 to August 31, 2025 2,088,156 $ 13.70 2,088,156 $ 496,084,464
−Removed: September 1, 2025 to September 30, 2025 2,069,160 $ 14.12 2,069,160 $ 466,871,937
+Added: October 1, 2025 to October 31, 2025 673,044 $ 13.35 673,044 $ 457,887,567
+Added: November 1, 2025 to November 30, 2025
+Added: 567,852 $ 13.07 567,852 $ 450,465,699
+Added: December 1, 2025 to December 31, 2025 3,253,248 $ 14.94 3,253,248 $ 401,871,946
On May 18, 2023, DXC announced that its Board approved an incremental $1.0 billion share repurchase authorization.
−Removed: As of September 30, 2025, approximately $467 million worth of shares remained available for repurchase under the plans or programs.
+Added: As of December 31, 2025, approximately $402 million remained available for repurchase under the plans or programs.
Share repurchases may be made from time to time through various means, including in open market purchases, 10b5-1 plans, privately-negotiated transactions, accelerated stock repurchases, block trades and other transactions, in compliance with Rule 10b-18 under the Exchange Act, as well as, to the extent applicable, other federal and state securities laws and other legal requirements.
9 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.